Ustekinumab HS Code Trade Classification — 7 Codes, $5.3M Trade

Q: How much Ustekinumab is exported under HS code 30021500?

Under HS code 30021500, India exports $3.6M worth of Ustekinumab, representing 68.3% of total Ustekinumab trade. This involves 233 shipments from 24 Indian exporters to 68 buyers in 20 countries.

Q: Which countries import the most Ustekinumab from India?

The top importing countries for Ustekinumab from India are Brazil, Japan, Saudi Arabia. The leading importer Brazil accounts for $909.9K in trade value. In total, Ustekinumab is exported to buyers across multiple countries under 7 HS code classifications.

Q: Who are the top Ustekinumab exporters from India?

The leading Ustekinumab exporters from India include JANSSEN PHARMACEUTICA N.V. ($1.7M), NEWLIFE MEDICALS USA INC ($556.8K), ESPEE BIOPHARMA & FINECHEM LLC ($553.6K). These suppliers export across multiple HS code classifications with a combined trade value of $5.3M.

TransData Nexus

Ustekinumab

India Pharmaceutical Trade Intelligence

$1.3M23 Suppliers10 CountriesHS 30021500

ExportsIndia → BRAZIL71.5%India → JAPAN12.6%

ImportsNETHERLANDS → India$1.5M UNITED STATES → India$1.1M

#1 Supplier: NIVIRA EXPORTS #1 Buyer: AS PER

Ustekinumab HS Codes (2026) — 7 Classifications, $5.3M Trade | TransData Nexus | TransData Nexus

Ustekinumab HS Code Analysis (2026)

India exports Ustekinumab under 7 distinct HS code classifications, representing a total trade value of $5.3M across 316 shipments. The dominant classification is HS 30021500 (Immunological products, put up in measured doses or for retail sale), accounting for 68.3% of all Ustekinumab trade at $3.6M. HS 30049099 (Other medicaments, put up in measured doses or for retail sale) follows at 29.4% ($1.6M). The top 5 HS codes together account for 100.0% of total Ustekinumab trade from India. The average transaction value is $16706. Key importing markets include Brazil, Japan, Saudi Arabia. Leading exporters include JANSSEN PHARMACEUTICA N.V. and NEWLIFE MEDICALS USA INC. Data sourced from Indian Customs (DGFT) shipping bill records.

Source:

Ustekinumab HS Code Analysis — 7 classifications, $5.3M trade value, top HS codes breakdown and distribution — Ustekinumab HS code analysis — 7 classifications · $5.3M trade value · 316 shipmentsTransData Nexus · Indian Customs Data

Top Ustekinumab HS Code Classifications

Ranked by trade value from Indian Customs (DGFT) data

Rank	HS Code	Trade Value	Share	Transactions	Avg Price	Suppliers	Countries
#1	30021500	$3.6M	68.3%	233	$2189.91	24	20
#2	30049099	$1.6M	29.4%

HS 30021500

Immunological products, put up in measured doses or for retail sale · 68.3% of Ustekinumab trade

$3.6M

Trade Value

68.3%

Market Share

233

Transactions

$2189.91

Avg Unit Price

Suppliers: 24Buyers: 68Countries: 20

Common Product Descriptions:

BMAB 1200 USTEKINUMAB

USTEKINUMAB BMAB 1200 INTERNAL

LIFE SAVING MEDICINE- EACH ML CONTAINS:USTEKINUMAB...

HS 30049099

Other medicaments, put up in measured doses or for retail sale · 29.4% of Ustekinumab trade

$1.6M

Trade Value

29.4%

Market Share

Transactions

$1660.34

Avg Unit Price

Suppliers: 17Buyers: 26Countries: 10

Common Product Descriptions:

Stelara 90mg-IN Ustekinumab /90mg/1ml BRANDStelara...

HARMLESS MEDICINE FOR HUMAN CONSUMPTIONUSTEKINUMAB...

Stelara 90mg-IN Ustekinumab /90mg/1ml BRAND Stelar...

HS 30021290

Other antisera and blood fractions · 1.2% of Ustekinumab trade

$61.9K

Trade Value

1.2%

Market Share

Transactions

$1187.64

Avg Unit Price

Suppliers: 2Buyers: 3Countries: 3

Common Product Descriptions:

USTEKINUMAB R-DNA ORIGIN

USTEKINUMAB (R-DNA ORIGIN)

ANTI USTEKINUMAB ANTIBODY 9A5 MAB MOUSE RECOMBINAN...

HS 30021500

Immunological products, put up in measured doses or for retail sale · 0.8% of Ustekinumab trade

$43.5K

Trade Value

0.8%

Market Share

Transactions

$1281.04

Avg Unit Price

Suppliers: 2Buyers: 4Countries: 1

Common Product Descriptions:

MEDICINES-EACH ML CONTAINS:USTEKINUMAB SOLUTION FO...

MEDICINES: EACH ML CONTAINS:USTEKINUMABSOLUTION FO...

STELARA 90MG-IN USTEKINUMAB /90MG/1ML, BRAND:STELA...

HS 30049099

Other medicaments of mixed or unmixed products (retail) · 0.3% of Ustekinumab trade

$17.7K

Trade Value

0.3%

Market Share

Transactions

$1356.07

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

HARMLESS MEDICINE FOR HUMAN CONSUMPTION OTHER DETA...

HS 30

Pharmaceutical product (Chapter 30) · 0.0% of Ustekinumab trade

$689

Trade Value

0.0%

Market Share

Transactions

$689.40

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

HUMAN ANTI USTEKINUMAB (FOR RESEARCH PURPOSE ONLY)...

HS 30029090

Other blood products, toxins, cultures of micro-organisms · 0.0% of Ustekinumab trade

$358

Trade Value

0.0%

Market Share

Transactions

$178.78

Avg Unit Price

Suppliers: 1Buyers: 1Countries: 1

Common Product Descriptions:

ATAD00100 Ustekinumab (0.1MG) FOR RESEARCH USE ONL...

Where Ustekinumab is Exported — Geographic HS Code Analysis

Import destinations for Ustekinumab from India, by trade value

India exports Ustekinumab to 10+ countries under 7 HS code classifications. The largest import destination is Brazil ($909.9K), followed by Japan ($160.7K) and Saudi Arabia ($125.8K). These markets collectively account for the majority of India's Ustekinumab pharmaceutical exports.

Rank	Country	Trade Value	Market Share
#1	Brazil	$909.9K	17.2%
#2	Japan	$160.7K	3.0%
#3	Saudi Arabia	$125.8K	2.4%
#4	Turkey	$36.9K	0.7%
#5	United Arab Emirates	$19.1K	0.4%
#6	Kenya	$9.7K	0.2%
#7	Cayman Islands	$4.5K	0.1%
#8	Mauritius	$2.8K	0.1%
#9	United Kingdom	$2.8K	0.1%
#10	Zimbabwe	$737	0.0%

Pharmaceutical buyers in these markets import Ustekinumab primarily under HS code 30021500 (Immunological products, put up in measured doses or for retail sale). Import duties, regulatory requirements, and product registration vary by destination country. Contact TransData Nexus for country-specific import intelligence.

Understanding Ustekinumab HS Codes

The Harmonized System (HS) is an internationally standardized system of names and numbers to classify traded products. Developed by the World Customs Organization (WCO), it is used by over 200 countries for customs tariffs, trade statistics, and regulatory compliance. Each HS code is a 6-digit number (extended to 8 digits in India's Customs Tariff Schedule) that precisely identifies a product category.

How Ustekinumab HS Codes Work

Ustekinumab falls under Chapter 30 (Pharmaceutical Products) of the Harmonized System. The 7 codes used for Ustekinumab exports span multiple headings:

Heading 3003 — Medicaments not put up in measured doses or for retail sale (bulk APIs, intermediates)
Heading 3004 — Medicaments put up in measured doses or for retail sale (finished formulations)
Heading 3005 — Wadding, gauze, bandages for medical use
Heading 3006 — Pharmaceutical goods (sutures, reagents, dental cements)

The most significant distinction for Ustekinumab is between HS 3003 (bulk/unmeasured) and HS 3004 (retail-ready). HS 3004 codes account for the majority of Ustekinumab trade (as finished formulations ready for dispensing). The 8-digit Indian Customs Tariff code further specifies the therapeutic class — for example, HS 30021500 refers to "Immunological products, put up in measured doses or for retail sale".

Regulatory & Compliance — Ustekinumab Export Classification

Correct HS code classification is critical for Ustekinumab exports from India. Misclassification can result in customs delays, incorrect duty assessment, and regulatory penalties. Key compliance considerations for pharmaceutical stakeholders:

Import Duty Classification

Ustekinumab import duties vary significantly by HS code and destination country. HS 3004 (finished formulations) typically attracts different duty rates than HS 3003 (bulk APIs). Many developing countries offer preferential rates for essential medicines including Ustekinumab.

DGFT & Indian Customs Requirements

Indian exporters must declare the correct 8-digit ITC-HS code on shipping bills filed with the Directorate General of Foreign Trade (DGFT). Ustekinumab exports require Drug Controller General of India (DCGI) approval and must comply with Drug & Cosmetics Act regulations.

WHO Prequalification

For international procurement (UNICEF, Global Fund), Ustekinumab products must meet WHO Prequalification standards. WHO PQ status affects which HS codes are eligible for preferential procurement pricing and duty exemptions in recipient countries.

Country-Specific Registration

Each destination country requires product registration before import. Key markets like Brazil and Japan have specific pharmaceutical regulatory bodies that must approve the product before customs clearance.

Related Biologics & Immunotherapy — Products Sharing Similar HS Codes

Other products in the Biologics & Immunotherapy therapeutic category that may share HS code classifications with Ustekinumab

adalimumab etanercept infliximab

Tariff Schedule — Top Markets

TransData Nexus Ustekinumab HS code trade compliance intelligence

1Tariff Schedule — Top Markets

Ustekinumab is primarily classified under HS code 30021500, which pertains to immunological products, put up in measured doses or in forms or packings for retail sale. The Most Favored Nation (MFN) tariff rates and any preferential rates under Free Trade Agreements (FTAs) for this HS code vary across our top importing countries:

Brazil: According to the World Trade Organization (WTO) tariff database, Brazil applies an MFN tariff rate of 8% on products under HS code 30021500. As of March 26, 2026, there is no specific FTA between Brazil and India that offers preferential rates for this product category.

Japan: Japan maintains an MFN tariff rate of 0% for HS code 30021500, as per the WTO tariff database. The Comprehensive Economic Partnership Agreement (CEPA) between India and Japan, effective since August 2011, also stipulates a 0% tariff rate for this category, facilitating duty-free access.

Saudi Arabia: The Saudi Customs Authority indicates an MFN tariff rate of 5% for HS code 30021500. There is no existing FTA between India and Saudi Arabia that provides preferential tariff rates for this product as of the current date.

Turkey: Turkey applies an MFN tariff rate of 0% on immunological products under HS code 30021500, according to the WTO tariff database. The India-Turkey FTA, effective since 2018, also offers a 0% tariff rate for this category, ensuring duty-free trade.

Classification Disputes & Misclassification Risks

TransData Nexus Ustekinumab HS code trade compliance intelligence

1Classification Disputes & Misclassification Risks

Ustekinumab, as an immunological product, is typically classified under HS code 30021500. However, our internal data indicates that seven different HS codes have been used across 316 shipments, with 68.3% of trade value associated with HS code 30021500. Other codes utilized include 30049099 (29.4%), 30021290 (1.2%), and minor instances of 30021500.0 and 30049099.0.

The primary distinction between HS codes 3003 and 3004 lies in the product's form:

HS code 3003: Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or forms for retail sale.

HS code 3004: Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or forms for retail sale.

Ustekinumab, being supplied in pre-filled syringes or vials for injection, should be classified under HS code 3004. Misclassification can occur when the product's presentation is not accurately considered, leading to incorrect tariff applications.

Common errors include:

Misclassifying pre-filled syringes under HS code 3003: This can result in incorrect duty assessments and potential customs penalties.

Pharmacopoeia & Quality Standards

TransData Nexus Ustekinumab HS code trade compliance intelligence

1Pharmacopoeia & Quality Standards

As of March 26, 2026, Ustekinumab does not have an official monograph in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), or Indian Pharmacopoeia (IP). The Indian Pharmacopoeia Commission's monograph submission checklist indicates that Ustekinumab is not listed in these pharmacopoeias.

In the absence of official monographs, quality standards for Ustekinumab are typically established by the manufacturer and approved by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These standards generally include:

Purity/Assay Requirements: Specifications for the active ingredient's purity, ensuring it meets the required potency and is free from contaminants.

Dissolution Testing: Although not always applicable to injectable products like Ustekinumab, dissolution testing may be relevant for certain formulations to ensure consistent bioavailability.

Stability Testing: Conducted in accordance with International Council for Harmonisation (ICH) guidelines, stability testing assesses the product's shelf life under various environmental conditions, including different ICH climatic zones.

Manufacturers are responsible for developing and validating these quality standards, which are then reviewed and approved by regulatory agencies to ensure the product's safety, efficacy, and quality.

Frequently Asked Questions — Ustekinumab HS Codes

Common questions about Ustekinumab trade classification, answered with data from Indian Customs records.

What is the HS code for Ustekinumab exports from India?

The most commonly used HS code for Ustekinumab exports from India is 30021500 (Immunological products, put up in measured doses or for retail sale), which accounts for 68.3% of all Ustekinumab trade valued at $3.6M. In total, India exports Ustekinumab under 7 distinct HS code classifications.

How many HS codes are used for Ustekinumab trade?

Ustekinumab is exported from India under 7 different HS code classifications, covering a total trade value of $5.3M across 316 shipments. The top 5 HS codes account for 100.0% of total trade.

What is HS code 30021500?

HS code 30021500 refers to "Immunological products, put up in measured doses or for retail sale" under Chapter 30 (Pharmaceutical Products) of the Harmonized System. For Ustekinumab, this code covers $3.6M in trade value with 233 transactions, 24 suppliers, and 68 buyers across 20 countries. The average unit price under this code is $2189.91.

What is the difference between HS 30021500 and 30049099 for Ustekinumab?

HS 30021500 (Immunological products, put up in measured doses or for retail sale) accounts for 68.3% of Ustekinumab trade ($3.6M) with an average unit price of $2189.91, while HS 30049099 (Other medicaments, put up in measured doses or for retail sale) covers 29.4% ($1.6M) at $1660.34 per unit. HS 30021500 involves 24 suppliers and 68 buyers, compared to 17 suppliers and 26 buyers for HS 30049099.

Official References & Regulatory Resources

HS code classifications follow the WCO Harmonized System. Verify tariff rates with your national customs authority.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ustekinumab

Ustekinumab

Top Ustekinumab HS Code Classifications

All Ustekinumab HS Code Classifications

HS 30021500

HS 30049099

HS 30021290

HS 30021500

HS 30049099

HS 30

HS 30029090

Top Suppliers

Related Analysis

Need HS Code Reports?

Where Ustekinumab is Exported — Geographic HS Code Analysis

Understanding Ustekinumab HS Codes

How Ustekinumab HS Codes Work

Regulatory & Compliance — Ustekinumab Export Classification

Import Duty Classification

DGFT & Indian Customs Requirements

WHO Prequalification

Country-Specific Registration

Related Biologics & Immunotherapy — Products Sharing Similar HS Codes

Tariff Schedule — Top Markets

1Tariff Schedule — Top Markets

Classification Disputes & Misclassification Risks

1Classification Disputes & Misclassification Risks

Pharmacopoeia & Quality Standards

1Pharmacopoeia & Quality Standards

Frequently Asked Questions — Ustekinumab HS Codes

What is the HS code for Ustekinumab exports from India?

How many HS codes are used for Ustekinumab trade?

What is HS code 30021500?

What is the difference between HS 30021500 and 30049099 for Ustekinumab?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

How much Ustekinumab is exported under HS code 30021500?

Which countries import the most Ustekinumab from India?

Who are the top Ustekinumab exporters from India?

Analysis Methodology